| Website | edmond-de-rothsch... |
| Phone | 01 40 17 70 38 |
| Employees | 6 |
| Founded | 1989 |
| Winch Capital 2, 11/09 | $377M |
Edmond de Rothschild IP focuses on acquiring interests in established unlisted companies. Investments are typically held for three to five years.
| Company | Date | Round | Size | Participants |
| CellNovo | 2/11 | Series B | £30M | 8 |
| SuperSonic Imagine | 11/10 | Series C | €34.5M | 6 |
| Covagen | 11/10 | Series A | $6.3M | 5 |
| Garden Price | 9/10 | Venture Round | €2M | 1 |
| Poxel | 8/10 | Series A | $20.3M | 3 |
| Implanet | 7/10 | Series D | $10.1M | 3 |
| Genticel | 4/10 | Series C | $17.7M | 4 |
| PDC Biotech | 2/10 | Series A | $5.5M | 2 |
| Smile | 1/10 | Venture Round | €2.5M | 1 |
| Regado Biosciences | 12/09 | Series D | $40M | 5 |
| Probiodrug | 11/09 | Series B | $54M | 8 |
| Endosense | 10/09 | Series B | $36M | 7 |
| GlycoVaxyn | 3/09 | Series B | $21.3M | 3 |
| AJ Tech | 4/08 | Series A | $1.25M | 1 |
| FastBooking | 10/07 | Series B | €35M | 2 |
| MeeVee | 9/07 | Series D | $3.5M | 6 |
| Cytomics Pharmaceuticals | 2/06 | Series B | €10M | 3 |
| MeeVee | 2/06 | Series B | $6.5M | 4 |
| Nautilus Biotech | 3/05 | Venture Round | €7.25M | 4 |
| MeeVee | 2/05 | Series A | $7M | 3 |